Candriam S.C.A. Merck & Co., Inc. Transaction History
Candriam S.C.A.
- $16.8 Billion
- Q2 2025
A detailed history of Candriam S.C.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 1,654,099 shares of MRK stock, worth $133 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
1,654,099
Previous 2,148,488
23.01%
Holding current value
$133 Million
Previous $193 Million
32.1%
% of portfolio
0.78%
Previous 1.24%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,858Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.73 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.59 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.76 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $204B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...